Terns Pharmaceuticals Inc

NASDAQ:TERN   3:38:22 PM EDT
11.83
+0.86 (+7.84%)
Earnings Announcements

Terns Pharmaceuticals Reports Second Quarter 2021 Financial Results And Corporate Highlights

Published: 08/16/2021 20:57 GMT
Terns Pharmaceuticals Inc (TERN) - Terns Pharmaceuticals Reports Second Quarter 2021 Financial Results and Corporate Highlights.
Terns Pharmaceuticals Inc - Qtrly Net Loss Was $10.7 Million.
Terns Pharmaceuticals Inc - Top-line Data Readout From Part 1 of Ongoing Aviation Trial of Tern-201 Expected in 1h 2022.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.64

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.73

More details on our Analysts Page.